Orbital - Vol. 17 No. 6 - October-December 2025
FULL PAPERS

Synthesis of 2-((5-(phenylamino)-1,3,4-thiadiazol-2-yl)thio)acetic Acid and Theoretical Evaluation of Its Biological Activity

Otaniyoz Ataniyazov
Urgench State University
Khudaybergan Polvonov
Urgench State University
Khushnudbek Eshchanov
Urgench State University
Rasul Okmanov
S. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan
Nurbek Razzokberdiev
Urgench State University

Published 2026-02-19

Keywords

  • Histamine H3 receptor,
  • thiadiazoles,
  • synthesis,
  • X-ray crystallography,
  • 2-((5-(phenylamino)-1,3,4-thiadiazol-2-yl)thio)acetic acid

How to Cite

(1)
Ataniyazov, O.; Polvonov, K.; Eshchanov, K.; Okmanov, R.; Razzokberdiev, N. . Synthesis of 2-(5-(phenylamino)-1,3,4-Thiadiazol-2-yl)thio)acetic Acid and Theoretical Evaluation of Its Biological Activity. Orbital: Electron. J. Chem. 2026, 17 (6), 551-559.

Abstract

2-((5-(phenylamino)-1,3,4-thiadiazol-2-yl)thio)acetic acid exhibits a variety of biological activities. Consequently, the synthesis, structure, and biological activity of this compound were investigated. The synthetic procedure is described in detail on a step-by-step basis, with the compound's composition and structure confirmed by FTIR, UV–Vis spectroscopy, and X-ray crystallography. Additionally, pharmacokinetic and toxicological properties were predicted using the ADMETPred program. The biological potential was further evaluated through the 3DStarPred program and molecular docking studies, which revealed high affinity for the human histamine H3 receptor, suggesting a potential role as an antagonist/inverse agonist in the central nervous system. Overall, these findings indicate that the synthesised compound represents a promising candidate for further medicinal development.

Downloads

Download data is not yet available.